Statement Of Cash Flows [Abstract]

Affluent Medical - Filing #858612

Concept 2022-01-01 to
2022-12-31
As at
2022-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
11 081 EUR
12 364 EUR
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
146,000 EUR
334,000 EUR
Cash flows from (used in) investing activities
146,000 EUR
160,000 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from borrowings, classified as financing activities
- EUR
795,000 EUR
Repayments of borrowings, classified as financing activities
50,000 EUR
- EUR
Payments of lease liabilities, classified as financing activities
360,000 EUR
283,000 EUR
Proceeds from government grants, classified as financing activities
- EUR
2 529 EUR
Interest paid, classified as financing activities
183,000 EUR
521,000 EUR
Other inflows (outflows) of cash, classified as financing activities
302,000 EUR
500,000 EUR
Cash flows from (used in) financing activities
2 401 EUR
18 281 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
- EUR
- EUR
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
8 826 EUR
5 757 EUR
Cash and cash equivalents
2 580 EUR
11 410 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.